Congressional Budget Office, which suggested the cost of the drugs could still exceed the savings from treating obesity and its attendant health conditions
However, clinical judgment should guide monitoring decisions based on individual patient characteristics
Boosts melanin Raises the enzyme responsible for producing skin-darkening pigment
Additionally, a study published in The Lancet in February 2026 found that taking Foundayo, Eli Lillys GLP-1 pill that was approved by the FDA in April, resulted in greater weight loss and blood sugar level reductions compared to Rybelsus, another oral GLP-1 manufactured by Novo Nordisk
Transdermal delivery systems may additionally cause local skin reactions , including redness, itching, or irritation at the application site